ApoB Cardiovascular Risk Calculator
Your 10-year heart attack and stroke risk — calculated the way modern cardiology actually does it. Includes ApoB, the single most important cardiovascular marker your doctor probably isn’t ordering.
The standard cholesterol panel your primary care doctor runs is half a century old. It tells you the weight of cholesterol in your blood, but not the thing that actually causes heart attacks — the number of atherogenic particles depositing into your artery walls. That’s what ApoB measures. And it predicts cardiovascular events more accurately than LDL, especially when LDL looks “fine.”
The 2018 AHA/ACC cholesterol guidelines and the 2022 European Atherosclerosis Society consensus statement both recommend ApoB testing for accurate risk assessment. Despite that, most primary care doctors still don’t order it — and a significant percentage of men with apparently “normal” cholesterol are walking around with ApoB levels that quietly classify them as high cardiovascular risk.
This calculator combines the standard ASCVD Pooled Cohort Equations (the official AHA/ACC 10-year risk model) with an ApoB adjustment so you can see how atherogenic particle burden modifies your number — and whether your LDL and ApoB are quietly disagreeing.
No email gate. No identifying information. The result is yours.
Why ApoB matters more than LDL
Every atherogenic lipoprotein in your bloodstream — LDL, VLDL, IDL, Lp(a), chylomicron remnants — carries exactly one apolipoprotein B molecule. Measuring ApoB counts the total number of these particles. Measuring LDL only counts the cholesterol carried inside them, which is a related but imperfect proxy. The two numbers usually agree. When they disagree, ApoB wins clinically every time.
Particles cause heart attacks, not weight
Plaque builds up when atherogenic lipoprotein particles cross the arterial wall and get trapped. The damage is driven by how many particles are doing this — not by how much cholesterol cargo each particle carries. Two men with identical LDL of 110 can have ApoB levels differing by 30 to 40 mg/dL, which translates directly into different rates of plaque progression. ApoB is measuring the thing that actually drives the disease.
“Normal” LDL with high ApoB is common
Roughly 20 percent of men with LDL under 130 (the “fine” range on a standard panel) have ApoB levels in the high or very high range. These men are walking around being told their cholesterol is normal — while carrying significantly elevated cardiovascular risk that their lipid panel misses entirely. This is one of the most common preventable causes of unexpected heart attacks in men under 60.
Calculate your risk
Default values shown are typical for a 50-year-old with mostly normal-looking labs. Replace them with your own numbers. The ASCVD model is validated for adults 40 to 79.
—
—
Where your ApoB sits
ApoB thresholds based on the 2018 AHA/ACC cholesterol guidelines. Lower is better — every 10 mg/dL reduction in ApoB is associated with roughly a 15% lower risk of cardiovascular events.
Order an ApoB-inclusive panel.
The ApexBlood comprehensive panel includes ApoB, hs-CRP, the full lipid panel, and the other Heart Health markers your primary care doctor isn’t ordering. Results in 3–5 business days. Rerun this calculator with your actual numbers and you have a real answer instead of an estimate.
Order ApexBlood Panel — $189 →Hormones interact with cardiovascular risk.
Testosterone influences lipid profiles, body composition, inflammation, and vascular function. For men over 40 with elevated cardiovascular risk, the hormonal angle is worth investigating directly — particularly if you also have low energy, poor recovery, or other low-T symptoms.
Explore TRT Consultation →What the risk number means
The 10-year ASCVD risk is the percentage chance of having a heart attack, stroke, or related cardiovascular event in the next decade. The AHA/ACC guidelines use specific thresholds to inform clinical decisions — particularly whether statin therapy is recommended.
Cardiovascular event risk in the next 10 years is low. For most adults in this band, lifestyle measures are the primary recommendation — staying active, maintaining a healthy weight, controlling blood pressure, and keeping lipid markers (including ApoB) in optimal ranges. The goal is preserving this position into the next decade, where age-related risk increases automatically. Periodic monitoring every 2 to 3 years catches any drift.
Risk in this band warrants attention to modifiable factors but typically doesn’t require pharmacological intervention on its own. The AHA/ACC guidelines recommend considering “risk-enhancing factors” — including elevated ApoB, high hs-CRP, family history of premature coronary disease, and metabolic syndrome — to refine the decision. Optimizing these markers can pull the number back into the low-risk band over 6 to 12 months.
Risk in this band typically warrants a real clinical conversation about both lifestyle intensification and potentially pharmacological intervention. The 2018 AHA/ACC guidelines recommend statin therapy for most adults in this range, especially when one or more risk-enhancing factors are present. ApoB testing is particularly valuable here — it informs both whether intervention is needed and how aggressive the lipid target should be.
High 10-year cardiovascular risk. Statin therapy is strongly recommended by current AHA/ACC guidelines, often at high intensity, along with aggressive management of blood pressure, glucose, weight, and lifestyle factors. The good news: this band has the largest absolute risk reduction from intervention — a properly treated person in this range typically sees their actual event rate drop substantially below the modeled number. The leverage point is the workup and the willingness to act on it.
What to do with this number
Two paths depending on where you landed and what you want to do next.
Order an ApoB-inclusive panel
The number above is an estimate. Replacing default values with your actual labs — including ApoB, which most standard panels don’t include — is what makes this calculator useful. The ApexBlood comprehensive panel covers ApoB, hs-CRP, the full lipid breakdown, HbA1c, eGFR, and the other markers worth running alongside for a real cardiovascular workup.
15 cardiovascular biomarkers including ApoB and hs-CRP — plus 50+ additional markers across metabolic, hormonal, liver, kidney, and inflammation categories. Free medical consultation included. Most primary care panels don’t include the Heart Health markers in this panel.
TRT consultation
Testosterone interacts with cardiovascular risk in several measurable ways. Low testosterone is associated with elevated cardiovascular event risk in observational studies, while properly managed testosterone replacement appears to be cardiovascularly neutral or slightly favorable in recent large trials (TRAVERSE 2023). For men over 40 with elevated risk and low-T symptoms, the hormonal angle is worth a real conversation alongside lipid management.
- Telehealth-based — no in-person visits required
- Licensed clinicians focused on men’s hormone optimization
- Cardiovascular monitoring included throughout treatment
- Transparent pricing — $97/month, no insurance gymnastics
The sequence that produces the best clinical outcomes is: real labs first, then the conversation. Walking into any medical consultation with current ApoB and hs-CRP values dramatically improves the quality of the discussion.
Frequently asked questions
Why doesn’t my doctor order ApoB?
Most primary care doctors run the same lipid panel they were trained on twenty or thirty years ago — total cholesterol, HDL, calculated LDL, and triglycerides. ApoB testing has been recommended by major cardiology guidelines since 2018, but adoption in primary care has been slow. Insurance coverage is inconsistent. Many doctors aren’t familiar enough with the marker to interpret it confidently. And the standard ASCVD risk calculator doesn’t require it. The result is that one of the most useful cardiovascular markers available remains an uncommon order in routine practice — usually requested only after a heart event has already happened. Ordering it directly, before something goes wrong, is one of the highest-yield preventive moves available to a middle-aged adult.
How accurate is the ASCVD risk calculator?
The Pooled Cohort Equations were derived from several large US cohort studies (ARIC, CARDIA, CHS, Framingham Offspring) totaling more than 24,000 adults with 10+ years of follow-up. They have well-documented limitations: they tend to overestimate risk in some populations, particularly more recent cohorts, and they were derived primarily from Black and non-Hispanic white participants. The 2023 AHA PREVENT equations are an updated alternative that addresses some of these limitations but isn’t yet widely used clinically. Both calculators produce statistical estimates, not predictions about specific individuals — they tell you what percentage of similar people would have an event over 10 years, not what will happen to you specifically.
What’s the difference between ApoB and LDL?
LDL cholesterol measures the weight of cholesterol carried inside one specific type of atherogenic particle. ApoB counts the total number of atherogenic particles in your blood — across all the lipoprotein types that can cause plaque (LDL, VLDL, IDL, Lp(a), chylomicron remnants). Every atherogenic particle has exactly one ApoB protein on its surface, so ApoB = particle count. When you have many small particles, your LDL can look fine while your ApoB is high — and the small-particle pattern is associated with significantly elevated cardiovascular risk that LDL misses. This is why ApoB is now the preferred risk marker in modern guidelines.
What’s a “good” ApoB level?
The 2018 AHA/ACC guidelines use the following ranges as general clinical guidance. Under 65 mg/dL is optimal — typical of people at very low cardiovascular risk and the target for those with established cardiovascular disease. 65 to 79 is desirable. 80 to 99 is average for the population but not optimal. 100 to 119 is borderline-high. 120 to 139 is high. Over 140 is very high. The relationship between ApoB and event rates is roughly linear and dose-dependent — each 10 mg/dL drop in ApoB is associated with roughly a 15% lower rate of cardiovascular events, across the full range studied.
What if my LDL is normal but my ApoB is high?
This is the discordance pattern, and it’s more common than most men realize — roughly 20% of men with LDL under 130 have ApoB levels in the high or very-high range. It usually reflects a “small dense LDL” particle phenotype: many small particles each carrying a modest cholesterol load. The total cholesterol weight looks fine, but the particle count is dangerous. This pattern is strongly associated with metabolic syndrome features (insulin resistance, abdominal obesity, elevated triglycerides) and carries cardiovascular risk well above what the lipid panel suggests. If this is your pattern, addressing the underlying metabolic dysfunction — diet, training, body composition, and in many cases testosterone optimization — typically improves both numbers over 3 to 6 months.
Does testosterone affect cardiovascular risk?
The data has evolved significantly. Older observational studies suggested possible cardiovascular harm from testosterone replacement, but those studies had serious methodological problems. The TRAVERSE trial published in 2023 — the largest randomized controlled trial of testosterone therapy ever conducted, with over 5,000 middle-aged and older men followed for several years — found that properly managed TRT did not increase cardiovascular events compared to placebo. Separately, low natural testosterone has been associated in multiple cohorts with elevated cardiovascular risk, possibly through effects on body composition, inflammation, glucose handling, and lipid metabolism. The current clinical consensus is that addressing low testosterone in symptomatic men appears to be cardiovascularly neutral or favorable, while leaving it untreated may carry quiet risk.
I’m under 40. Can I still use this?
The ASCVD Pooled Cohort Equations are only validated for ages 40 to 79. For adults under 40, the calculator will refuse to compute a 10-year risk — the model doesn’t have enough event data in that age range to be reliable. That said, ApoB is still a useful marker for younger adults, particularly those with family history of premature heart disease. The lifetime risk calculation (a separate model) becomes more relevant in younger populations. For men under 40 concerned about cardiovascular risk, the right move is getting an ApoB-inclusive panel for baseline data and having a clinical conversation about lifetime rather than 10-year risk.
Does this calculator save my data?
No. Your inputs exist only in your browser session. Nothing is stored, logged, or attached to any account. You can run the calculator as many times as you want without anything being saved on our end.
The most important cardiovascular marker is the one your doctor isn’t ordering.
Heart attacks in middle-aged men are the most preventable killer in modern medicine — and the single biggest leverage point is having the right data before something goes wrong. ApoB testing is no longer optional in modern cardiovascular workup. If you don’t have a recent number, the next step is straightforward.
This calculator is for educational purposes only and does not constitute medical advice. The ASCVD Pooled Cohort Equations are a population-level statistical model with documented limitations including overestimation in some populations. The ApoB modifier shown is a clinical adjustment derived from observational research and not a validated replacement for the standard equation. Cardiovascular risk assessment and treatment decisions should be made with a qualified clinician based on your complete medical picture.